Abstract:The fat mass and obesity-associated enzyme (FTO) can catalyze the demethylation of N6-methyladenosine (m6A) residues in mRNA, regulates the cellular level of m6A modification, and plays a critical role in human obesity and cancers. Herein, we develop a single-quantum-dot (QD)-based fluorescence resonance energy transfer (FRET) sensor for the identification of specific FTO demethylase inhibitors. The FTO-mediated demethylation of m6A can induce the cleavage of demethylated DNA to generate the biotinylated DNA fragments, which may function as capture probes to assemble the Cy5-labeled reporter probes onto the QD surface, enabling the occurrence of FRET between the QD and Cy5. The presence of inhibitors can inhibit the FTO demethylation and consequently abolish FRET between the QD and Cy5. The inhibition effect of inhibitors upon FTO demethylation can be simply evaluated by monitoring the decrease of Cy5 counts. We use this nanosensor to screen several small-molecule inhibitors and identify diacerein as a highly selective inhibitor of FTO. Diacerein can inhibit the demethylation activity of endogenous FTO in HeLa cells. Interestingly, diacerein is neither a structural mimic of 2-oxoglutarate (2-OG) nor a chelator of metal ions, and it can selectively inhibit FTO demethylation by competitively binding the m6A-containing substrate.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c02828?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c02828</a>.Sequence of oligonucleotides and the optimization of experimental conditions (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c02828/suppl_file/ac0c02828_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Crystal Structure of the FTO Protein Reveals Basis for Its Substrate Specificity

Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)

A Novel Inhibitor of the Obesity-Related Protein FTO.

Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

FTO gene polymorphisms and obesity risk in Chinese population: a meta-analysis

FTO regulates adipogenesis by controlling cell cycle progression via mA-YTHDF2 dependent mechanism.

Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates

FTO is a Transcriptional Repressor to Auto-Regulate Its Own Gene and Potentially Associated with Homeostasis of Body Weight.

Structural Insights into FTO's Catalytic Mechanism for the Demethylation of Multiple RNA Substrates

Fluorescein Derivatives As Bifunctional Molecules for the Simultaneous Inhibiting and Labeling of Fto Protein

Comprehensive mutations analyses of FTO (fat mass and obesity-associated gene) and their effects on FTO’s substrate binding implicated in obesity

Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m<SUP>6</SUP>A methylation and increasing the stability of SREBF1 and ChREBP mRNAs

FTO levels affect RNA modification and the transcriptome

Polymorphism in 5 ' Regulatory Region of the Porcine Fat Mass and Obesity Associated (fto) Gene is Associated with Intramuscular Fat Content in A Jinhua X Pietrain F-2 Reference Population

Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs

The ‘Fat Mass and Obesity Related’ (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance

Identification of Specific N 6 -Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors

Identification of Natural Compound Radicicol As a Potent FTO Inhibitor.

The Fat Mass and Obesity Associated Gene Fto Functions in the Brain to Regulate Postnatal Growth in Mice

SFPQ is an FTO-Binding Protein That Facilitates the Demethylation Substrate Preference.